Dosimetry and first clinical evaluation of the new 18F-radiolabeled bombesin analogue BAY 864367 in patients with prostate cancer

Sah, Bert-Ram; Burger, Irene A.; Schibli, Roger; Friebe, Matthias; Dinkelborg, Ludger; Graham, Keith; Borkowski, Sandra; Bacher-Stier, Claudia; Valencia, Ray; Srinivasan, Ananth; Hany, Thomas F.; Mu, Linjing; Wild, Peter J.; Schaefer, Niklaus G.

doi:10.2967/jnumed.114.147116

Metadata only

Author

Bacher-Stier, Claudia

Date

2015-03

Type

Journal Article

Citations

Cited 46 times in Web of Science

Cited 50 times in Scopus

ETH Bibliography

yes

Altmetrics

Publication status

published

External links

https://doi.org/10.2967/jnumed.114.147116

Journal / series

The Journal of Nuclear Medicine

Volume

56(3)

Pages / Article No.

372 - 378

Publisher

Society of Nuclear Medicine

Subject

Prostate cancer; GRP receptor imaging; Gastrin-releasing peptide; 18 F-radiolabeled bombesin analogue; Dosimetry

Organisational unit

03688 - Schibli, Roger / Schibli, Roger

Notes

Published online 12 February 2015.

More

Show all metadata

Citations

Cited 46 times in Web of Science

Cited 50 times in Scopus

ETH Bibliography

yes

Altmetrics

Research Collection

Search

Dosimetry and first clinical evaluation of the new 18F-radiolabeled bombesin analogue BAY 864367 in patients with prostate cancer Mendeley CSV RIS BibTeX

Dosimetry and first clinical evaluation of the new 18F-radiolabeled bombesin analogue BAY 864367 in patients with prostate cancer

Mendeley

CSV

RIS

BibTeX